English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 6 October 2023, 21:00 JST

Source: Olympus
Olympus Names Dr. John de Csepel as Chief Medical Officer
Driving the Medical and Scientific Affairs Division to provide the highest level of patient access and safety

Olympus Corporation (Olympus), a global MedTech company committed to making people's lives healthier, safer and more fulfilling, named Dr. John de Csepel to the role of Chief Medical Officer (CMO), effective immediately.

In this role, John will report to CEO Stefan Kaufmann and drive the globally integrated Medical and Scientific Affairs Division (MSA) with a wealth of experience and remarkable track record in healthcare. Olympus is devoted to developing safe medical devices with demonstrable clinical and economic value to reduce the social burden of healthcare costs while improving healthcare outcomes for all.

Dr. John de Csepel
Dr. John de Csepel

"As a leading global MedTech company, we must deliver optimal medical care that prioritizes patient safety to meet the expectations of our stakeholders. Today, I am delighted to announce an exciting new leader to take the team to even greater heights," said Shigeto Ohtsuki, Olympus Chief Human Resources Officer. "We look forward to the innovative ideas, expertise, and leadership that Dr. de Csepel will bring us as we continue contributing to the advancement of healthcare."

The MSA team aims to improve patient outcomes by elevating the standard of care through minimally invasive solutions across targeted diseases while delivering above-market, sustainable growth.

John joins Olympus from Medtronic, where he most recently served as the Global Regions Chief Medical Officer. He played a pivotal role in driving innovative relationships with healthcare providers and enhancing patient access to care through his leadership in clinical research and medical science. Before that, he headed the Medical Affairs teams at both Barrx Medical and Covidien's Surgical business, demonstrating exceptional leadership and expertise in the MedTech industry. Concurrent with his management experience, he has worked as a volunteer war surgeon for Doctors Without Borders (Médecins Sans Frontiéres) from 2006 through 2014 and since then as a New York City trauma surgeon on the weekends.

John holds a bachelor's degree in business administration and a doctorate in medicine from Georgetown University, Washington D.C. He was a General Surgery Resident and Laparoscopic Surgery Fellow at the Mount Sinai School of Medicine in New York and subsequently served as Chief of Minimally Invasive of Surgery at New York's Saint Vincent's Hospital. He continues to reside in New York, U.S.A.

About Olympus

At Olympus, we are committed to Our Purpose of making people's lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide best-in-class solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit https://www.olympus-global.com/ and follow our global X account: @Olympus_Corp.

Media contact:
Nao Tsukamoto
Tel: +81-80-8853-9124
Mail: Global-Public_Relations@olympus.com

Olympus Corp [TYO: 7733] [ADR: OLYMY] [STU: OLY1] [FRA: OLYS] https://www.olympus-global.com

Topic: Executive appointment
Source: Olympus

Sectors: Healthcare & Pharm, HR, MedTech
From the Asia Corporate News Network

Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Olympus Related News
Wednesday, 12 June 2024, 11:00 JST
Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India
Wednesday, 27 March 2024, 15:00 JST
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System
Wednesday, 24 January 2024, 15:00 JST
Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd
Monday, 11 December 2023, 11:00 JST
Olympus Named to Dow Jones Sustainability World Index for Three Consecutive Years
Thursday, 7 December 2023, 11:00 JST
Vesica AI Selected as Winner of Inaugural Olympus Asia Pacific Innovation Program
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575